These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5973379)

  • 1. [Immunity against poliomyelitis 6 and 4 years following oral vaccination].
    Just M; Ritzel G
    Schweiz Med Wochenschr; 1966 Dec; 96(51):1710-2. PubMed ID: 5973379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of the effectiveness of oral vaccination against poliomyelitis. Immunity of the Geneva population 4 years after the vaccination].
    Du Pan RM; Bavaud C; Koechli B
    Schweiz Med Wochenschr; 1967 Aug; 97(33):1063-7. PubMed ID: 5588031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of oral vaccination against poliomyelitis].
    Henneberg G
    Munch Med Wochenschr; 1969 Aug; 111(35):1701-8. PubMed ID: 5820235
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the immunitary condition among children in Savona and the diffusion of poliovirus in the 3 years following mass antipoliomyelitic vaccination].
    Deveris B; De Flora S; Di Stefano G
    G Ig Med Prev; 1968; 9(2):130-41. PubMed ID: 4314815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunity of children and adolescents to poliomyelitis before and after type 3 oral vaccination, and immunity of unvaccinated infants in the Olsztyn Province].
    Rodkiewicz T; Weglińska T
    Przegl Epidemiol; 1972; 26(2):201-4. PubMed ID: 5070976
    [No Abstract]   [Full Text] [Related]  

  • 6. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral vaccination against poliomyelitis in the province of Lecce].
    Magliari G; Rubino V
    Ann Sanita Pubblica; 1966; 27(5):1051-70. PubMed ID: 5993987
    [No Abstract]   [Full Text] [Related]  

  • 8. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of vaccine-induced poliomyelitis immunity.
    Mayer TR
    J Fam Pract; 1984 Sep; 19(3):385-6, 388. PubMed ID: 6470639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunoglobulin level in the saliva of children with poliomyelitis and healthy children following oral vaccination with live attenuatea strain of type 2 and 3 poliovirus].
    Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
    Pol Tyg Lek; 1970 Feb; 25(8):281-3. PubMed ID: 5417312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Virological studies during vaccination with Sabin vaccine].
    Congiu A; Scarpa B
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):1005-6. PubMed ID: 5969307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):653-7. PubMed ID: 5997193
    [No Abstract]   [Full Text] [Related]  

  • 13. [History and results of a campaign against poliomyelitis].
    Rotta C; Fiandaca S
    Minerva Med; 1967 Aug; 58(61):2755-9. PubMed ID: 6049069
    [No Abstract]   [Full Text] [Related]  

  • 14. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IMMUNITY TO POLIOMYELITIS 4 YEARS FOLLOWING ORAL VACCINATION].
    JUST M; RITZEL G
    Schweiz Med Wochenschr; 1965 Jan; 95():1-4. PubMed ID: 14306411
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
    Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
    Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].
    Rümke HC; Oostvogel PM; van der Veer M; van Steenis G; van Loon AM
    Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1380-6. PubMed ID: 8240513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.